VR (nerve agent)

Overview of the nerve agent VR

Overview

Error creating thumbnail:

Chemical structure of VR nerve agent

VR, also known as "Russian VX," is a nerve agent that belongs to the class of organophosphates. It is chemically similar to VX, one of the most well-known nerve agents, but differs slightly in its molecular structure. VR is a highly toxic compound that affects the nervous system by inhibiting the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and continuous stimulation of muscles, glands, and central nervous system structures.

Chemical Properties

VR is an organophosphorus compound with the chemical formula C11H26NO2PS. It is a clear, colorless to amber-colored liquid at room temperature. The compound is odorless and tasteless, making it difficult to detect without specialized equipment. Like other nerve agents, VR is highly lipophilic, allowing it to penetrate biological membranes easily.

Mechanism of Action

The primary mechanism of action of VR is the inhibition of the enzyme acetylcholinesterase. This enzyme is responsible for breaking down acetylcholine, a neurotransmitter, in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to continuous stimulation of cholinergic receptors. This results in muscle paralysis, respiratory failure, and potentially death if not treated promptly.

Symptoms of Exposure

Exposure to VR can occur through inhalation, ingestion, or skin contact. Symptoms of exposure include:

• Miosis (constricted pupils)
• Rhinorrhea (runny nose)
• Bronchoconstriction
• Muscle twitching
• Seizures
• Respiratory distress
• Loss of consciousness

Treatment

Error creating thumbnail:

VR is similar in structure to VX

The treatment for VR exposure involves the administration of antidotes such as atropine and pralidoxime. Atropine works by blocking the effects of acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase. Supportive care, including ventilation and oxygen therapy, is also critical in managing severe cases.

History and Development

VR was developed during the Cold War as part of the Soviet Union's chemical weapons program. It was designed to be a more potent alternative to VX, with similar properties but increased toxicity. The existence of VR was not widely known until after the dissolution of the Soviet Union, when details of the program were revealed.

Related pages

• Nerve agent
• VX (nerve agent)
• Organophosphate poisoning
• Chemical warfare